| RS886039624 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS886039625 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS886039626 |
PALB2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039627 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS886039628 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS886039629 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886039630 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS886039631 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039632 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS886039633 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS886039634 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039635 |
PALB2
|
Health Risk |
Likely pathogenic |
— |
| RS886039636 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886039637 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS886039638 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS886039639 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886039640 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS886039641 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS886039642 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS886039643 |
ATM
|
Health Risk |
Likely pathogenic |
— |
| RS886039644 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886039645 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886039646 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS886039647 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS886039648 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS886039649 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886039650 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS886039651 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS886039652 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS886039653 |
WWOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS886039654 |
TGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS886039655 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS886039656 |
TERC
|
Health Risk |
Pathogenic |
— |
| RS886039657 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS886039658 |
KMT2A
|
Health Risk |
Likely pathogenic |
Microcephaly, Microcephaly |
| RS886039659 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS886039660 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS886039661 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039662 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS886039663 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886039664 |
SOX10
|
Health Risk |
Pathogenic |
PCWH syndrome, PCWH syndrome |
| RS886039665 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS886039666 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS886039667 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS886039668 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS886039669 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS886039670 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS886039671 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS886039672 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS886039673 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS886039674 |
EYA1
|
Health Risk |
Pathogenic |
— |
| RS886039675 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS886039676 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886039677 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS886039678 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS886039679 |
ARID1B
|
Health Risk |
Pathogenic |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS886039680 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886039681 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886039682 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS886039683 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886039685 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Blepharocheilodontic syndrome 1, Hereditary diffuse gastric adenocarcinoma |
| RS886039686 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886039687 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS886039688 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886039689 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS886039690 |
PDHA1
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS886039691 |
PIGL
|
Health Risk |
Pathogenic |
— |
| RS886039692 |
CHD8
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS886039693 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS886039694 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS886039695 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS886039696 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS886039697 |
ATM
|
Health Risk |
Pathogenic |
— |
| RS886039698 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS886039699 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886039700 |
SOX9
|
Health Risk |
Pathogenic |
— |
| RS886039701 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS886039702 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS886039703 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS886039704 |
DNM2
|
Health Risk |
Pathogenic |
— |
| RS886039705 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886039706 |
HDAC8
|
Health Risk |
Pathogenic |
— |
| RS886039707 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS886039708 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS886039709 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886039710 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS886039711 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS886039712 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886039713 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886039714 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS886039715 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS886039716 |
CDC73
|
Health Risk |
Pathogenic |
— |
| RS886039717 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886039718 |
CUL4B
|
Health Risk |
Pathogenic |
— |
| RS886039719 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS886039720 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS886039721 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Thyroid cancer |
| RS886039722 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS886039724 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886039725 |
CHD8
|
Health Risk |
Pathogenic |
— |